Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22261812 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Clinical Trial of Sutent to Treat Metastatic Melanoma
Condition: Metastatic Melanoma
Intervention: Drug: Sutent (sunitinib)

Indicates status has not been verified in more than two years